Lumpy skin disease vaccine developed by Bharat Biotech group firm with ICAR gets CDSCO licence

Daily Current Affairs / Lumpy skin disease vaccine developed by Bharat Biotech group firm with ICAR gets CDSCO licence

Change Language English Hindi

Category : Science and Tech Published on: February 17 2025

Share on facebook

Biovet, a Bharat Biotech group firm, received CDSCO approval for Biolumpivaxin, the world's first DIVA marker vaccine for lumpy skin disease (LSD) in cattle and buffaloes, developed in collaboration with ICAR.
This vaccine received approval from the Central Drugs Standard Control Organization (CDSCO) for commercial use.

PM Narendra Modi to inaugurate the first SOUL Leadership Conclave at Bharat Mandapam, New Delhi, on 21st February.
Read More....
Bharat Petroleum Corporation collaborates with National Sugar Institute, Kanpur, for research and development.
Read More....
Dr. Bhagyashree Prasad Patil received the Vishalakshi Award 2025 from President Droupadi Murmu.
Read More....
Microsoft unveils Majorana 1, the world’s first quantum processor with topological qubits.
Read More....
MoD signs ₹1,220 crore contract with BEL for Software Defined Radios.
Read More....
IRDAI launches Bima-ASBA via UPI to simplify insurance premium payments.
Read More....
Nagaland Forest Management Project wins SKOCH Award for forest conservation and livelihood improvement.
Read More....
In-Space to fund early space technologies for commercial product development.
Read More....
Kash Patel becomes the first Indian-American FBI director, confirmed by the U.S. Senate with a 51-49 vote.
Read More....
The government extends Chief Economic Advisor V Anantha Nageswaran's tenure until March 2027.
Read More....

Lumpy skin disease vaccine developed by Bharat Biotech group firm with ICAR gets CDSCO licence